New York, United States, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Capsules are a preferred dosage form across all the demographic subsets following its ease of handling and swallowing, palatability, and consumer compliance. Increasing innovations in the pharmaceutical industry is further adding fuel to the market growth. For instance, as of 2018, nearly 7,000 medicines under clinical development globally, Pharmaceutical Research and Manufacturers of America (PhRMA). As per U.S. FDA analysis, the number of drugs approved for capsule dosage forms has increased from 53 to 110. Moreover, across phase I to phase III clinical studies, nearly 35,000 participants are using capsules as a preferred dosage form.
Capsules are popular among the manufacturers as it allows flexibility in the formulation. Encapsulation, as a better technology, has been preferred to formulate complex molecules as it allows the filling of granules, powder, liquids, and pellets. A hard gel tin capsule is considered as a flexible dosage form because it simplifies the testing of drug candidates and reduces the concerns of compressibility.
Download Free Sample Report PDF @ https://straitsresearch.com/report/empty-capsule-market/request-sample
Market Dynamics
Ongoing Trend of Veganism to Drive the Demand for Non-Gelatin Capsules
Global empty capsules market has been segmented by type, application and end user. Non-gelatine capsules segment is expected to grow at the fastest CAGR till 2026. The key factor attributed to this is an upward trend towards consumption of vegan products. For instance, in the U.K, production of vegan products increased to 600,000 in 2017. Additionally, in response to the growing trend of vegan products, nutrition supplement manufacturers have started manufacturing vegan supplements. Moreover, government of various countries are taking initiatives to replace gelatine with cellulose in the capsule formulations.
Preventive Healthcare to Boost the demand for Nutrition Supplements and Nutraceuticals
Capsules are a preferred dosage form across all the demographic subsets following its ease of handling and swallowing, palatability, and consumer compliance. Increasing innovations in the pharmaceutical industry is further adding fuel to the market growth. For instance, as of 2018, nearly 7,000 medicines under clinical development globally, Pharmaceutical Research and Manufacturers of America (PhRMA). As per U.S. FDA analysis, the number of drugs approved for capsule dosage forms has increased from 53 to 110. Moreover, across phase I to phase III clinical studies, nearly 35,000 participants are using capsules as a preferred dosage form.
Capsules are popular among the manufacturers as it allows flexibility in the formulation. Encapsulation, as a better technology, has been preferred to formulate complex molecules as it allows the filling of granules, powder, liquids, and pellets. A hard gel tin capsule is considered as a flexible dosage form because it simplifies the testing of drug candidates and reduces the concerns of compressibility.
Segmental Analysis
Ongoing Trend of Veganism to Drive the Demand for Non-Gelatin Capsules
Global empty capsules market has been segmented by type, application and end user. Non-gelatine capsules segment is expected to grow at the fastest CAGR till 2026. The key factor attributed to this is an upward trend towards consumption of vegan products. For instance, in the U.K, production of vegan products increased to 600,000 in 2017. Additionally, in response to the growing trend of vegan products, nutrition supplement manufacturers have started manufacturing vegan supplements. Moreover, government of various countries are taking initiatives to replace gelatine with cellulose in the capsule formulations.
Regional Analysis
Asia Pacific to Emerge as the Fastest Growing Market over the Forecast Period
Asia Pacific market is majorly driven by countries such as Japan, China, India, and Australia as a result of rising geriatric population, increasing chronic disease burden, and proliferating pharmaceutical industries in the region. India pharmaceutical market is expected to grow at a CAGR of over 16% till 2020. Moreover, Indian pharmaceutical manufacturers are increasingly investing in developing new pharmaceutical therapies. For instance, in 2017, an Indian pharmaceutical company received 304 Abbreviated New Drug Application (ANDA) approval from the U.S. FDA.
Europe is second leading empty capsules market. Increasing geriatric population is responsible for the market growth. For instance, it is estimated that geriatric population in this region is expected to grow from nearly 17% in 2013 to around 30% by 2050. Moreover, Europe is one of the largest consumers of dietary supplements. According to the National Diet and Nutrition Survey, over 30% of adults aged between 19 and 64 years consumes dietary products every day. In addition, under-nutrition and associated complications cost approximately 120 billion Euros to the European health and social care systems. Increasing trend of consuming vegan products in the region is further expected to offer market opportunities for vegetarian capsules.
Ask for Customization @ https://straitsresearch.com/report/empty-capsule-market/request-sample
Key Highlights:
- The global empty capsule market size was valued at USD 3.81 billion in 2024 and is projected to reach from USD 3.95 billion in 2025 to USD 5.28 billion by 2033, growing at a CAGR of 3.71% during the forecast period (2025-2033).
- Based on the type, the gelatine capsules segment was the major contributor to the global market in 2022.
- Based on application, The antibiotic and antibacterial drugs segment is leading the empty capsule market during forecast period.
- Based on the end user, The pharmaceutical industry dominates the market owing to consumers' shifting trend toward capsule dosage forms during forecast period.
- Based on regional analysis, North America will have the largest share in the market, advancing at a CAGR of 7.1% during the forecast period.
Competitive Players
- ACG (India)
- Bright Pharma Caps Inc. (U.S)
- CapsCanada (Canada)
- Lonza (Switzerland)
- Medi-Caps Ltd. (India)
- Mitsubishi Chemical Holdings Corporation (Japan)
- Roxlor LLC (U.S)
Recent Developments
- November 2023- CapsCanada® Corporation received a significant boost in the form of a USD 5 million investment from FedDev Ontario, which will be used to expand operations and meet rising demand for its made-in-Canada hard empty capsules.
- August 2023- Bright Pharma Caps Inc. created Bright-Poly organic capsules, the world's first certified ones. The capsules are made from USDA-certified organic pullulan and NOP-approved and can be used in vegetarian, kosher, and halal products.
- February 2023- Vivion, a global ingredient solutions provider, introduced a new line of empty gelatin, HPMC, and pullulan capsules.
Segmentation
By Type
- Gelatine
- Non gelatine
By Application
- Antibiotic and antibacterial drugs
- Vitamins and dietary supplements
- Antacid and antiflatulent preparations
- Antianemic preparations
- Anti-inflammatory and anti-rheumatic drugs
- Cardiac therapy drugs
- Cough and cold preparations
- Other therapeutic applications
By End user
- Pharmaceutical
- Nutraceuticals
- Cosmetics
By Region
- North America
- Europe
- Asia Pacific
- Middle East And Africa
- Latin America
Get Detailed Market Segmentation @ https://straitsresearch.com/report/empty-capsule-market/segmentation
About Straits Research Pvt. Ltd.
Straits Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.
Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches.
Phone: +1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
Email: sales@straitsresearch.com
Follow Us: LinkedIn | Facebook | Instagram | Twitter
